KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Jun 05, 2023 $9.73 $9.92 $9.54 $9.59 71 596
Jun 02, 2023 $9.86 $9.99 $9.70 $9.74 109 091
Jun 01, 2023 $9.91 $9.97 $9.60 $9.77 109 217
May 31, 2023 $9.53 $10.11 $9.28 $9.90 304 799
May 30, 2023 $9.85 $10.12 $9.37 $9.52 104 084
May 26, 2023 $9.94 $10.82 $9.84 $9.97 147 885
May 25, 2023 $11.20 $11.20 $9.77 $10.70 151 063
May 24, 2023 $11.29 $11.29 $10.80 $11.20 102 898
May 23, 2023 $11.51 $12.08 $11.42 $11.43 102 108
May 22, 2023 $11.51 $11.91 $11.42 $11.51 70 736
May 19, 2023 $11.86 $12.06 $11.48 $11.53 66 116
May 18, 2023 $11.91 $12.08 $11.68 $11.85 86 704
May 17, 2023 $11.75 $12.21 $11.31 $11.90 87 544
May 16, 2023 $11.61 $11.99 $11.37 $11.75 86 579
May 15, 2023 $12.10 $12.42 $11.75 $11.81 96 592
May 12, 2023 $12.42 $12.87 $11.88 $12.05 86 740
May 11, 2023 $11.67 $12.42 $11.61 $12.42 217 096
May 10, 2023 $11.96 $12.06 $11.08 $11.50 263 071
May 09, 2023 $12.44 $12.47 $11.94 $11.95 118 107
May 08, 2023 $11.94 $12.93 $11.77 $12.41 215 027
May 05, 2023 $12.40 $13.17 $11.64 $11.85 292 485
May 04, 2023 $12.79 $12.95 $12.39 $12.51 174 522
May 03, 2023 $13.06 $13.67 $12.29 $12.80 340 508
May 02, 2023 $14.24 $14.76 $12.90 $13.06 419 757
May 01, 2023 $11.59 $16.11 $11.26 $14.29 1 825 585
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT